A decade ago, lip filler was the surest way for a young woman to broadcast money and social capital with a single appointment. Now, according to reporting in The Cut and analysis from Daily Wire contributor Dr. Debra Soh, a new status signal has taken its place: the GLP-1 injection.
The shift tracks a broader cultural swing back toward extreme thinness, echoing the 1990s heroin-chic aesthetic that has been revived across fashion and social media. Where millennials once contended with low-rise denim and tiny tank tops — armed mostly with bronzer and hair extensions — Gen Z now has access to injectable medications that can reshape the body on a timeline that once seemed unthinkable.
According to Soh’s piece in The Daily Wire, young women on college campuses are pursuing dramatic weight loss specifically to gain social standing, date “upward,” and compete for spots in top sorority houses. Some, per The Cut’s reporting cited by Soh, describe weighing cocaine against Ozempic as they chase their target weight.
What the Drugs Do — and What They Cost
Patients on a GLP-1 medication can expect to lose between 15 and 25 percent of their body weight over roughly a year, a result that has made the drugs enormously popular. Soh notes that 12 percent of U.S. adults have used a GLP-1, with use concentrated among adolescents and young adults — particularly females, and particularly in the South.
The appeal is easy to understand. Celebrities who have visibly transformed their silhouettes have normalized the look, in some cases to a degree that has prompted concern even among fans. But the drugs carry a list of potential side effects that goes well beyond the cosmetic. Soh cites nausea, vomiting, stomach paralysis, intestinal obstruction, brain injury, and vision loss as possible complications, and notes that the long-term effects remain inadequately studied.
Legal exposure for manufacturers is mounting. More than 4,000 patients have filed lawsuits against the companies that make the drugs, alleging that the risks were not adequately disclosed. That number, Soh writes, is expected to grow.
A Treatment, or a New Eating Disorder?
Perhaps the most uncomfortable question raised by the trend is whether the medication itself is becoming a vehicle for disordered eating. Clinicians have warned that GLP-1s may worsen symptoms in patients already at risk for eating disorders, and that using them for casual or purely aesthetic weight loss could itself constitute a new form of disordered eating.
Some users, Soh observes, don’t exercise at all — a signal that the decision was driven less by health than by speed and ease. Others obtain the medication outside the conventional medical system: through telehealth startups, WhatsApp groups, foreign suppliers, or friends. Those routes generally bypass proper medical supervision, raising the odds of unsafe use.
Then there’s the question of what happens after. A patient who starts a GLP-1 eventually has to decide when to stop — and how thin is thin enough. Unless she intends to stay on the medication indefinitely, there is a real possibility of regaining the weight within about two years of quitting.
The Influence Economy
Social media has intensified the pressure. Soh argues that photo-editing apps and filters — once dismissed as harmless fun — have trained young people to believe that radical physical transformation is both achievable and effortless. Greater exposure to appearance-focused content, she notes, is associated with higher risk of eating disorders and weight-related anxiety.
She points to one influencer interviewed by The Cut who had posted openly about recovering from an eating disorder. The influencer attributed her thin frame to Pilates while, in fact, using a semaglutide compound similar to Ozempic. When followers asked for her workout routine, she said she felt “a little weird” about not being forthcoming.
Soh is careful to add a caveat: it isn’t acceptable to accuse someone you don’t know of using a GLP-1 or having an eating disorder. Some people are simply naturally thin.
Even so, the growing normalization of the drugs carries its own stigma risk. As GLP-1 use becomes routine, Soh warns, it can reinforce the belief that no one has an excuse to be overweight — a quick fix exists, the logic goes, even if its side effects are alarming.
Competing in a Global Marketplace
The dating landscape, in Soh’s telling, has made the calculus worse. Both men and women now compete not just with people in their town or on their campus, but with the most attractive people in the world. Young women know that the men they’re interested in can follow and interact with models and influencers who have millions of followers — a form of direct access that previous generations never had to contend with.
Faced with that comparison, many women will do whatever they can to optimize what they’ve been given. The result is a high-stakes race that Soh says is being run largely by people too young to see how the trade-offs will look a decade out.
For those already struggling with disordered eating or negative body image, her recommendation is to consult a mental health professional rather than focus on weight. To young women who feel trapped in the competition, her broader message is that the priorities of youth inevitably shift with age — and that a momentary glow-up isn’t worth trading health or mental well-being for.
Beauty standards, she notes, have always been unattainable. Just as overfilled lips have fallen out of fashion, each successive fad will follow. The beauty industry, currently valued at roughly $700 billion, will always be hungry for more.
If you or someone you know is struggling with an eating disorder, help is available through the National Eating Disorders Association helpline.
Source: www.dailywire.com — https://www.dailywire.com/news/forget-lip-filler-gen-zs-new-beauty-obsession-is-far-more-dangerous